Henrietta Lacks’ Descendants Awarded Settlement After Pharmaceutical Company Used Her Cells for Medical Science Without Permission Over 70 Years Ago

The relatives of Henrietta Lacks, a Black woman whose cells were taken without her knowledge decades ago without her consent have reached a confidential settlement with the biotechnology company Thermo Fisher Scientific.

The success of the legal case may lead to more complaints seeking compensation for the use and to gain control over Lacks’ cells. Her “HeLa” cells were the first in the world capable of replicating outside the body.

Henrietta Lacks Family Gets Settlement
Left photo: Henrietta Lacks’ grandchildren Ron Lacks, his cousin Al Lacks and sister Donnie Lacks with his father Lawrence Lacks. Right photo: Henrietta Lacks (Photos: Courtesy of Hope Lacks/File)

Attorneys for the family announced the agreement at a news conference in Baltimore on Tuesday, July 31, which coincides with what would have been Lacks’ 103rd birthday.

“The parties are pleased that they were able to find a way to resolve this matter outside of Court and will have no further comment about the settlement,” said civil rights attorney Benjamin Crump in a statement.

Lacks’ relatives filed the lawsuit two years ago, exactly 70 years after the day Lacks died. Thermo Fisher Scientific previously had argued that the descendants waited too long to take legal action and claimed that many other companies globally also use HeLa cells without explicit consent.

Henrietta Lacks underwent cervical cancer treatment in 1951 but died a few months after diagnosis. Her cells were later discovered to regenerate outside the body, and they have been instrumental in developing polio and COVID-19 vaccines, as well as the world’s most common fertility treatment.

In their lawsuit, Lacks’ grandchildren and other descendants highlighted her treatment as a significant example of ongoing medical racism that persists to this day.

“The American pharmaceutical community has a shameful history of profiting off research at the expense of Black people without their knowledge, consent, or benefit, leading to mass profits for pharmaceutical companies from our illnesses and our very bodies,” Crump said. “There is no clearer example of this than Henrietta Lacks and the seemingly endless manipulation of her genetic material.”

Last week, a bill to award the Congressional Gold Medal posthumously to Lacks was introduced by U.S. Sen. Chris Van Hollen and U.S. Sen. Ben Cardin, both Democrats from Maryland.

In a statement announcing the bill, Hollen acknowledged that Lacks profoundly influenced modern medicine.

“It is long past time that we recognize her life-saving contributions to the world,” he said.

Independent journalism still matters.

We hope this story was worth your time. For over 14 years, Atlanta Black Star has stayed Black-owned and independently run. We didn't get here by waiting on ad budgets that were never built to prioritize us. Our readers did that.

Corporate support for Black media has always been thin. Outlets like ours get roughly 1% of the $170 billion spent on U.S. advertising each year, and that margin is shrinking further as advertisers walk back the DEI-linked commitments they made in 2020. That's the backdrop. It's not why we're asking.

The wider picture isn't any steadier. Newspaper ad revenue has fallen more than 80% since 2005, and local newsrooms are closing at a rate of roughly two a week nationwide. When outlets go under, it's rarely the ones built to center a Black perspective from the ground up that get to stick around.

We know a request for support isn't why you came here. But without readers choosing to fund this work directly, the depth of reporting we can do at home and abroad shrinks along with everyone else's. If you're not in a position to give, that doesn't change how much we value you as a reader.

If you are able to, a recurring contribution does more for us than a single one-time gift, because it lets us plan the next investigation instead of just the next invoice. It takes about 30 seconds, no long form, no account. Thank you for continuing to support independent journalism and freedom of the press.

Back to top